Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
+6,605,695
Put/Call ratio
7.9%
SEC-reported price per share
$40.18
Number of holders
311
Value change
+$263,400,168
Number of buys
175
Open additional details 1 more signal available
Number of sells
109
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
445,144,313

Security key

G7709Q104

Report period

Q3 2022

Institutions

311

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 5
MORGAN STANLEY 12%
FMR LLC 8.1%
VANGUARD GROUP INC 7.4%
BlackRock Finance, Inc. 4.1%
BAILLIE GIFFORD & CO 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13F
Company
13F
12%
$2,166,876,000
51,543,171 shares
30 Jun 2022
FMR LLC
13F
Company
13F
8.1%
$1,511,480,000
35,953,344 shares
30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
7.4%
$1,381,172,000
32,853,776 shares
30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
4.1%
$773,439,000
18,397,640 shares
30 Jun 2022
BAILLIE GIFFORD & CO
13F
Company
13F
4%
$756,506,000
17,994,918 shares
30 Jun 2022
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
3.8%
$702,397,000
16,707,815 shares
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
311
Shares
298,186,963
Rows available
311
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
281
Q3 2022 holders
311
Holder diff
30
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .